In Table 1 of the Annex to Regulation (EU) No 37/2010, the following substance is inserted in alphabetical order:
Pharmacologically active substance | Marker residue | Animal species | MRL | Target tissues |
Other provisions
(according to Article 14(7) of Regulation (EC) No 470/2009)
Therapeutic classification
‘Tildipirosin | Tildipirosin | Bovine, caprine | 400 μg/kg | Muscle |
Not for use in animals from which milk is produced for human consumption.
The MRL for muscle shall not apply to the injection site, where residue levels shall not exceed 11500 μg/kg.
Provisional MRL shall expire on 1 January 2012.
Macrolide’
200 μg/kg | Fat
2000 μg/kg | Liver
3000 μg/kg | Kidney
Porcine | 1200 μg/kg | Muscle |
The MRL for muscle shall not apply to the injection site, where residue levels shall not exceed 7500 μg/kg.
Provisional MRL shall expire on 1 January 2012.
800 μg/kg | Skin and fat
5000 μg/kg | Liver
10000 μg/kg | Kidney